CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

Clinical Potential of Combining AI and Decentralized Clinical Trials

Life Sciences Review | Saturday, December 19, 2020
Tweet

Leveraging AI and DCTs has become the core imperative to developing safe therapies as fast as possible.


FREMONT, CA: For years, enhancing clinical trial outcomes has focused on lowering time and cost. That focus, and the challenges of a pandemic, has triggered the digitization of the clinical trial life cycle. Decentralized Clinical Trials (DCTs), which put the patient at the heart of the trial experience and combine digital technologies, and artificial intelligence (AI), are joining forces to transform clinical research. Organizations are coupling DCT methodologies with AI in innovative means to reshape workflows across the clinical lifecycle, from trial design and patient recruitment to evidence generation. They are seeing dramatic decreases in time and cost of clinical studies. Read on to know more.


With the analytical tools and AI, the industry can benefit from this rich data to optimize patient recruitment, boost patient retention, reduce timelines, and maximize study results in future trials. AI can expedite target validation, trial design, and patient identification. DCTs can reduce the time and cost of clinical studies by widening patient access and retention due to enabling patients to participate safely and conveniently in their homes. 


DCTs also mitigate geographic, transportation, costs, and other hurdles that can enhance participants' diversity. The net impact is an enhancement in data quality as site-based transcription is avoided, plus an increase in efficiency for patients, sites, and study teams. Together, AI and DCTs can be a powerful tool.


To deploy AI with purpose, AI engines need more than just mountains of data. To offer accuracy, the data requires to be closely representative of the target population. As has been highly publicized in recent months, conventional clinical trials are often comprised of participants from urban areas and are predominantly white. DCTs drive AI engines since they inherently gather massive real-world, real-time data from diverse patient populations more inclusive of the world. By coupling both innovations, firms will enhance three crucial clinical trials, including trial design, patient recruitment, and evidence generation. AI’s continued maturation will widen its use across all stages of the patient journey and will lead to incredible breakthroughs in personalized medicine to rare diseases.


Check out: Top eClinical Trial Management Solution Companies


Weekly Brief

loading
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/clinical-potential-of-combining-ai-and-decentralized-clinical-trials--nwid-212.html